Oral mucosa lesions and oral symptoms in inflammatory bowel disease patients

Bibliographic Details
Main Author: Laranjeira, Nuno
Publication Date: 2015
Other Authors: Fonseca, Jorge, Meira, Tânia, Freitas, João, Valido, Sara, Leitão, Jorge
Format: Article
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10400.26/9563
Summary: "Background - Inflammatory Bowel Disease is known for its extra intestinal manifestations, the oral cavity is no exception. Objectives - The aim of this study was to evaluate the association between Inflammatory Bowel Disease and oral mucosa lesions and symptoms, and complementary to evaluate their possible relation with oral hygiene, smoking habits, drug therapy, duration and activity of the disease. Methods - Patients were selected from the Gastroenterology Clinic of a Portuguese tertiary referral hospital. This sample consisted of 113 patients previously diagnosed with ulcerative colitis or Crohn’s disease along with a control group of 58 healthy individuals that were accompanying the study group patients to their appointments. Clinical interviews and clinical examinations were performed for data collection. Results - The patients in the study group were more affected by oral symptoms (P=0.011), and showed a trend towards a higher incidence of oral mucosal lesions, even though statistical significance was not reached (8.8% versus 3.4% in the control group; P=0.159). Patients in active phase were the most affected. No differences were detected between Crohn’s disease and ulcerative colitis, or concerning smoking habits. The corticosteroid and immunosuppressant therapy seemed to increase the incidence of oral symptoms (P=0.052). The oral mucosa lesions increased and the oral symptoms decreased over the course of the disease, however without statistical significance. Conclusion - Oral mucosa’s lesions and oral symptoms were positively associated with Inflammatory Bowel Disease, mainly during disease activity periods and conceivably, associated with corticosteroid and immunosuppressant therapy."
id RCAP_b73b9fb5f29b1cb8e1fcf6cd13bd7b59
oai_identifier_str oai:comum.rcaap.pt:10400.26/9563
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Oral mucosa lesions and oral symptoms in inflammatory bowel disease patientsInflammatory bowel diseasesAphthous stomatitisMouth mucosa"Background - Inflammatory Bowel Disease is known for its extra intestinal manifestations, the oral cavity is no exception. Objectives - The aim of this study was to evaluate the association between Inflammatory Bowel Disease and oral mucosa lesions and symptoms, and complementary to evaluate their possible relation with oral hygiene, smoking habits, drug therapy, duration and activity of the disease. Methods - Patients were selected from the Gastroenterology Clinic of a Portuguese tertiary referral hospital. This sample consisted of 113 patients previously diagnosed with ulcerative colitis or Crohn’s disease along with a control group of 58 healthy individuals that were accompanying the study group patients to their appointments. Clinical interviews and clinical examinations were performed for data collection. Results - The patients in the study group were more affected by oral symptoms (P=0.011), and showed a trend towards a higher incidence of oral mucosal lesions, even though statistical significance was not reached (8.8% versus 3.4% in the control group; P=0.159). Patients in active phase were the most affected. No differences were detected between Crohn’s disease and ulcerative colitis, or concerning smoking habits. The corticosteroid and immunosuppressant therapy seemed to increase the incidence of oral symptoms (P=0.052). The oral mucosa lesions increased and the oral symptoms decreased over the course of the disease, however without statistical significance. Conclusion - Oral mucosa’s lesions and oral symptoms were positively associated with Inflammatory Bowel Disease, mainly during disease activity periods and conceivably, associated with corticosteroid and immunosuppressant therapy."IBEPEGE, CBCD, SBMD, FBG, SBH, SOBEDRepositório ComumLaranjeira, NunoFonseca, JorgeMeira, TâniaFreitas, JoãoValido, SaraLeitão, Jorge2015-08-03T10:18:40Z2015-042015-04-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.26/9563eng0004-28031678-421910.1590/S0004-28032015000200006info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-04-01T17:04:30Zoai:comum.rcaap.pt:10400.26/9563Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-29T04:47:36.934093Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Oral mucosa lesions and oral symptoms in inflammatory bowel disease patients
title Oral mucosa lesions and oral symptoms in inflammatory bowel disease patients
spellingShingle Oral mucosa lesions and oral symptoms in inflammatory bowel disease patients
Laranjeira, Nuno
Inflammatory bowel diseases
Aphthous stomatitis
Mouth mucosa
title_short Oral mucosa lesions and oral symptoms in inflammatory bowel disease patients
title_full Oral mucosa lesions and oral symptoms in inflammatory bowel disease patients
title_fullStr Oral mucosa lesions and oral symptoms in inflammatory bowel disease patients
title_full_unstemmed Oral mucosa lesions and oral symptoms in inflammatory bowel disease patients
title_sort Oral mucosa lesions and oral symptoms in inflammatory bowel disease patients
author Laranjeira, Nuno
author_facet Laranjeira, Nuno
Fonseca, Jorge
Meira, Tânia
Freitas, João
Valido, Sara
Leitão, Jorge
author_role author
author2 Fonseca, Jorge
Meira, Tânia
Freitas, João
Valido, Sara
Leitão, Jorge
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório Comum
dc.contributor.author.fl_str_mv Laranjeira, Nuno
Fonseca, Jorge
Meira, Tânia
Freitas, João
Valido, Sara
Leitão, Jorge
dc.subject.por.fl_str_mv Inflammatory bowel diseases
Aphthous stomatitis
Mouth mucosa
topic Inflammatory bowel diseases
Aphthous stomatitis
Mouth mucosa
description "Background - Inflammatory Bowel Disease is known for its extra intestinal manifestations, the oral cavity is no exception. Objectives - The aim of this study was to evaluate the association between Inflammatory Bowel Disease and oral mucosa lesions and symptoms, and complementary to evaluate their possible relation with oral hygiene, smoking habits, drug therapy, duration and activity of the disease. Methods - Patients were selected from the Gastroenterology Clinic of a Portuguese tertiary referral hospital. This sample consisted of 113 patients previously diagnosed with ulcerative colitis or Crohn’s disease along with a control group of 58 healthy individuals that were accompanying the study group patients to their appointments. Clinical interviews and clinical examinations were performed for data collection. Results - The patients in the study group were more affected by oral symptoms (P=0.011), and showed a trend towards a higher incidence of oral mucosal lesions, even though statistical significance was not reached (8.8% versus 3.4% in the control group; P=0.159). Patients in active phase were the most affected. No differences were detected between Crohn’s disease and ulcerative colitis, or concerning smoking habits. The corticosteroid and immunosuppressant therapy seemed to increase the incidence of oral symptoms (P=0.052). The oral mucosa lesions increased and the oral symptoms decreased over the course of the disease, however without statistical significance. Conclusion - Oral mucosa’s lesions and oral symptoms were positively associated with Inflammatory Bowel Disease, mainly during disease activity periods and conceivably, associated with corticosteroid and immunosuppressant therapy."
publishDate 2015
dc.date.none.fl_str_mv 2015-08-03T10:18:40Z
2015-04
2015-04-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.26/9563
url http://hdl.handle.net/10400.26/9563
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 0004-2803
1678-4219
10.1590/S0004-28032015000200006
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv IBEPEGE, CBCD, SBMD, FBG, SBH, SOBED
publisher.none.fl_str_mv IBEPEGE, CBCD, SBMD, FBG, SBH, SOBED
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833602154698375168